Sirios Capital Management L P Boston Scientific Corp Transaction History

Sirios Capital Management L P

$506 Million
Q1 2024

A detailed history of Sirios Capital Management L P transactions in Boston Scientific Corp stock. As of the latest transaction made, Sirios Capital Management L P holds 260,185 shares of BSX stock, worth $19.3 Million. This represents 3.52% of its overall portfolio holdings.

Number of Shares

260,185

Previous 426,266 38.96%

Holding current value

$19.3 Million

Previous $24.6 Million 27.68%

% of portfolio

3.52%

Previous 5.26%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$57.6 - $68.62 $9.57 Million - $11.4 Million	-166,081 Reduced 38.96%	260,185 $17.8 Million
Q4 2023 Feb 14, 2024	SELL	$48.64 - $57.81 $3.23 Million - $3.84 Million	-66,360 Reduced 13.47%	426,266 $24.6 Million
Q3 2023 Nov 14, 2023	BUY	$50.19 - $54.68 $3.04 Million - $3.31 Million	60,472 Added 13.99%	492,626 $26 Million
Q2 2023 Aug 14, 2023	SELL	$49.72 - $54.64 $1.28 Million - $1.4 Million	-25,669 Reduced 5.61%	432,154 $23.4 Million
Q1 2023 May 15, 2023	SELL	$45.09 - $50.03 $4.36 Million - $4.83 Million	-96,589 Reduced 17.42%	457,823 $22.9 Million

Q4 2022 Feb 14, 2023	BUY	$39.56 - $47.22 $424,122 - $506,245	10,721 Added 1.97%	554,412 $25.7 Million
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $1.87 Million - $5.59 Million	-50,972 Reduced 8.57%	543,691 $21.1 Million
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $9.45 Million - $12.6 Million	268,070 Added 82.08%	594,663 $22.2 Million
Q1 2022 May 13, 2022	SELL	$40.9 - $45.1 $866,998 - $956,029	-21,198 Reduced 6.1%	326,593 $14.5 Million
Q4 2021 Feb 14, 2022	SELL	$38.07 - $44.87 $4.09 Million - $4.83 Million	-107,539 Reduced 23.62%	347,791 $14.8 Million
Q3 2021 Nov 15, 2021	SELL	$41.23 - $45.88 $1.7 Million - $1.89 Million	-41,122 Reduced 8.28%	455,330 $19.8 Million
Q2 2021 Aug 16, 2021	SELL	$38.58 - $44.24 $8.43 Million - $9.66 Million	-218,402 Reduced 30.55%	496,452 $21.2 Million
Q1 2021 May 14, 2021	SELL	$35.27 - $39.67 $12.2 Million - $13.8 Million	-346,943 Reduced 32.68%	714,854 $27.6 Million
Q4 2020 Feb 16, 2021	BUY	$33.15 - $41.97 $11.3 Million - $14.3 Million	339,571 Added 47.02%	1,061,797 $38.2 Million
Q3 2020 Nov 13, 2020	BUY	$34.44 - $42.23 $6.12 Million - $7.51 Million	177,743 Added 32.64%	722,226 $27.6 Million
Q2 2020 Aug 14, 2020	SELL	$30.19 - $39.11 $11.4 Million - $14.7 Million	-376,633 Reduced 40.89%	544,483 $19.1 Million
Q1 2020 May 15, 2020	SELL	$25.83 - $45.71 $4.16 Million - $7.35 Million	-160,898 Reduced 14.87%	921,116 $30.1 Million
Q4 2019 Feb 14, 2020	BUY	$37.87 - $45.37 $96,530 - $115,648	2,549 Added 0.24%	1,082,014 $48.9 Million
Q3 2019 Nov 13, 2019	SELL	$40.31 - $43.45 $764,680 - $824,246	-18,970 Reduced 1.73%	1,079,465 $43.9 Million
Q2 2019 Aug 14, 2019	SELL	$34.91 - $42.98 $17.7 Million - $21.8 Million	-507,478 Reduced 31.6%	1,098,435 $47.2 Million
Q1 2019 May 15, 2019	BUY	$32.91 - $40.75 $10 Million - $12.4 Million	304,009 Added 23.35%	1,605,913 $61.6 Million
Q4 2018 Feb 14, 2019	SELL	$31.73 - $39.04 $32 Million - $39.4 Million	-1,008,345 Reduced 43.65%	1,301,904 $46 Million
Q3 2018 Nov 13, 2018	SELL	$32.83 - $38.63 $2.78 Million - $3.27 Million	-84,605 Reduced 3.53%	2,310,249 $88.9 Million
Q2 2018 Aug 14, 2018	SELL	$26.84 - $34.32 $14.1 Million - $18.1 Million	-526,049 Reduced 18.01%	2,394,854 $78.3 Million
Q1 2018 May 14, 2018	BUY	$25.2 - $28.54 $7.35 Million - $8.33 Million	291,697 Added 11.09%	2,920,903 $79.8 Million
Q4 2017 Feb 12, 2018	BUY	$24.79 - $29.8 $18.2 Million - $21.8 Million	732,944 Added 38.65%	2,629,206 $65.2 Million
Q3 2017 Nov 13, 2017	BUY	$26.26 - $29.17 $49.8 Million - $55.3 Million	1,896,262	1,896,262 $55.3 Million

Others Institutions Holding BSX

# of Institutions

1,354

Shares Held

1.17B

Call Options Held

6.01M

Put Options Held

5.97M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $106B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sirios Capital Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Sirios Capital Management L P with notifications on news.

Account

Sirios Capital Management L P Boston Scientific Corp Transaction History